Union Pharmacist results, Q2 2023
Net profit, assets, equity and cash flow for Q2 2023, against the same period a year earlier, from the published financial statements.
Net profit-2.94 millionEGP · −3861.3% vs the same period a year earlier
Total assets59.91 millionEGP · −2.8% vs the same period a year earlier
Shareholders' equity8.7 millionEGP · −40.2% vs the same period a year earlier
Operating cash flow47.28 millionEGP · +3945.5% vs the same period a year earlier
In short
- Union Pharmacist's net profit for Q2 2023 was about -2.94 million EGP, down −3861.3% from 78.22 thousand EGP in Q2 2022.
- Total assets at the end of Q2 2023 were about 59.91 million EGP, and shareholders' equity about 8.7 million EGP.
- Operating cash flow for Q2 2023 was positive at 47.28 million EGP.
Key lines against the same period a year earlier
This periodQ2 2022Change
Net profit-2.94 million78.22 thousand−3861.3%
Gross profit1.44 million138 thousand+945.2%
Total assets59.91 million61.62 million−2.8%
Total liabilities51.21 million47.05 million+8.8%
Shareholders' equity8.7 million14.56 million−40.2%
Total liabilities and equity59.91 million61.62 million−2.8%
Operating cash flow47.28 million-1.23 million+3945.5%
Investing cash flow———
Net change in cash47.28 million-1.23 million+3945.5%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Union Pharmacist's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy